Keyphrases
Therapeutic Efficacy
100%
Cotton
100%
Proton Pump Inhibitors
100%
Esomeprazole
100%
Lung Injury Model
100%
Lung Injury
25%
Chronic Lung Disease
25%
Mouse Model
12%
Lung
12%
Epithelial Cells
12%
Biological Activity
12%
Fibrosis
12%
Lung Inflammation
12%
Inflammation Markers
12%
Chronic Obstructive Pulmonary Disease
12%
Stomach
12%
Clinical Observation
12%
Clinical Reports
12%
Fibrosis Marker
12%
Parietal Cell
12%
Idiopathic Pulmonary Fibrosis
12%
Antifibrotic
12%
Pharmacological Efficacy
12%
Profibrotic
12%
Beneficial Outcomes
12%
Proton Pump
12%
Antacids
12%
Endothelial Cell Function
12%
K+-ATPase
12%
Lung Fibrosis
12%
Immune Cell Function
12%
Antioxidant Mechanism
12%
Bleomycin-induced Lung Injury
12%
Gastric Disorders
12%
Circulating Markers
12%
Retrospective Clinical Study
12%
Pharmacology, Toxicology and Pharmaceutical Science
Combination Therapy
100%
Proton Pump Inhibitor
100%
Esomeprazole
100%
Fibrosis
25%
Chronic Lung Disease
25%
Mouse Model
12%
Inflammation
12%
Biological Activity
12%
Antioxidant
12%
Pneumonia
12%
Clinical Study
12%
Anti-Inflammatory Drug
12%
Chronic Obstructive Lung Disease
12%
Stomach Disorders
12%
Fibrosing Alveolitis
12%
Adenosine Triphosphatase (Potassium)
12%
Lung Fibrosis
12%
Antacid Agent
12%
Proton Pump
12%
Bleomycin-Induced Lung Injury
12%